N-acetylcysteine in Intra-amniotic Infection/Inflammation

Conditions

Chorioamnionitis | Infection | Inflammation | Labor, Premature | Preterm Premature Rupture of the Membranes

What is the purpose of this trial?

The aim of the study is to determine if N-acetylcysteine (a potent free radical scavenger) prevents the occurrence of adverse neonatal outcomes in preterm deliveries complicated by infection associated with preterm labor or preterm premature rupture of membranes (PPROM). The working hypothesis is that in pregnancies complicated by intra-amniotic infection or inflammation, N-acetylcysteine protects the fetus by preventing the development, or decreasing the intensity and/or progression of the fetal inflammatory syndrome.



Participation Guidelines

Age:
18 Years and older
Gender:
Female

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale University
Dates:
October 2006
Last Updated:
July 18, 2012
Study HIC#:
0603001228

Clinicaltrials.gov ID: NCT00397735